Component
Common cold recovery rate
Common cold recovery rate; read each linked claim for the measured context and model.
1 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
What acts on it
The tested commercial lozenge did not significantly improve ten-day recovery: zinc/placebo recovery-rate ratio .68 (95% CI .42–1.08; P=.10).
Experimental context and source evidence
- cross_nutrient
- Zinc exposure and the specifically measured response.
- evidence_location
- Indexed primary abstract; accessible manuscript Methods and Results also inspected.
- evidence_span
- {"source_cache": "artifacts/zinc-clinical-sources/hemila2020.abstract.txt", "locator": "Primary indexed abstract; complete local file", "file_sha256": "581a713c4eeae243c2c96cb508cfe731318175d77c781476575775c09b6e9913", "utf8_bytes": 2004}
- experimental_model
- Double-blind randomized placebo-controlled Finnish trial: 253 packages allocated; 87 colds analyzed
- exposure
- Commercial acetate lozenges: 13 mg elemental zinc, six times daily, at most five days; nominal 78 mg/day.
- limitations
- This specific formulation dissolved in about eight minutes. Authors extended planned seven-day recovery analysis to ten days after finding no significant difference. Results do not identify why other formulations differ.
- nutrient_topic
- Zinc research collection; topical membership is not evidence of a direct dietary effect. · Zinc
- organism
- Homo sapiens
- plain_language
- A different acetate-lozenge regimen did not show faster recovery.
- primary_references
- [zn-clin-hemila2020] Zinc acetate lozenges for the treatment of the common cold: a randomised controlled trial. (2020). https://pubmed.ncbi.nlm.nih.gov/31980506/ DOI: 10.1136/bmjopen-2019-031662
- tissue_or_cell_type
- Upper respiratory symptoms and tolerability
Zinc: transport, enzyme loading, deficiency and nutrient interactions (2026-09-17) · lines 1558–1571
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Double-blind randomized placebo-controlled Finnish trial: 253 packages allocated; 87 colds analyzed · source_derived_draft · unverified_draft
### zn-clin-cold-recovery-null The tested commercial lozenge did not significantly improve ten-day recovery: zinc/placebo recovery-rate ratio .68 (95% CI .42–1.08; P=.10). Condition category: normal nutrient_topic: Zinc research collection; topical membership is not evidence of a direct dietary effect. plain_language: A different acetate-lozenge regimen did not show faster recovery. organism: Homo sapiens tissue_or_cell_type: Upper respiratory symptoms and tolerability experimental_model: Double-blind randomized placebo-controlled Finnish trial: 253 packages allocated; 87 colds analyzed limitations: This specific formulation dissolved in about eight minutes. Authors extended planned seven-day recovery analysis to ten days after finding no significant difference. Results do not identify why other formulations differ. exposure: Commercial acetate lozenges: 13 mg elemental zinc, six times daily, at most five days; nominal 78 mg/day. cross_nutrient: Zinc exposure and the specifically measured response. evidence_location: Indexed primary abstract; accessible manuscript Methods and Results also inspected. evidence_span: {"source_cache": "artifacts/zinc-clinical-sources/hemila2020.abstract.txt", "locator": "Primary indexed abstract; complete local file", "file_sha256": "581a713c4eeae243c2c96cb508cfe731318175d77c781476575775c09b6e9913", "utf8_bytes": 2004} [zn-clin-hemila2020] Zinc acetate lozenges for the treatment of the common cold: a randomised controlled trial. (2020). https://pubmed.ncbi.nlm.nih.gov/31980506/ DOI: 10.1136/bmjopen-2019-031662
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.